arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

AIBOTICS, INC.

AIBT
— Price unavailable
Materials ·Medicinal Chemicals & Botanical Products ·USMedicinal Chemicals & Botanical Products
9 Visible periods
16 Metrics
Peer-ranked Benchmarks
Price Chart
61
Health
Fair
Bullish
auto_awesome

Analytical Summary

AIBOTICS, INC. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap —
Dividend Yield —
Revenue Growth —
Op. Margin —
ROIC 46.6% ↘
FCF / Share —
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity —
info Valuation on last close.

9-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$2.18K
— —
Net Income Profit after all expenses
$-2.22M
↓ -19.9% —
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Returns ↑
97
Financial Health ↑
32
Cash Quality ↑
29

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 9 years · 35 quarters